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Introduction.Diﬀerentanthropometricvariableshavebeenshowntoberelatedtocardiovascularmorbidityandmortality.Ouraim
was to compare the association between diﬀerent anthropometric measurements and inﬂammatory status. Methods and results.
A cross-sectional study design in which we analyzed the data collected during a ﬁve-year period in the Tel Aviv Medical Center
Inﬂammation Survey (TAMCIS). Included in the study were 13,033 apparently healthy individuals at a mean (SD) age of 43. Of
these,8,292weremaleand4,741female.Asigniﬁcantage-adjustedandmultiple-adjustedpartialcorrelationwasnotedbetweenall
anthropometricmeasurementsandallinﬂammatorybiomarkers.Therewasnosigniﬁcantdiﬀerencein thecorrelation coeﬃcients
between diﬀerent biomarkers and anthropometric variables. Conclusion. Most of the common used anthropometric variables are
similarly correlated with inﬂammatory variables. The clinician can choose the variable that he/she ﬁnds easiest to use.
1.Introduction
Diﬀerent anthropometric variables have been shown to be
related to cardiovascular morbidity and mortality. Of these
variables, body mass index (BMI) and waist circumference
are amongst the most common and part of the metabolic
syndrome. In addition, it has been shown that peripheral fat
deposition is associated with less severe, and central obesity
related to more severe, cardiovascular disease [1–3].
It is well known that inﬂammation and central obesity
are related [4, 5], however, there is a lack of agreement
regarding which anthropometric variables have the best
correlation with inﬂammation. Since atherosclerosis is a in-
ﬂammatory disease [6], we set out to compare the corre-
lation between diﬀerent anthropometric measurements and
inﬂammation. Such knowledge will help in deﬁning which
physical measure should be used in evaluating proinﬂamma-
tory body habitus.
2. Methods and Procedures
2.1. Participants. We have presently analyzed data that has
been collected during the last ﬁve years in the Tel Aviv
MedicalCenterInﬂammationSurvey(TAMCIS),aregistered
data bank of the Israeli Ministry of Justice [7]. This is
a relatively large cohort of individuals who attended our
medical centre for a routine annual checkup and gave their
written informed consent for participation according to the
instructions of the institutional ethics committee. A total of
17,393 subjects gave their informed consent (10,975 males,
6,418 females). Later, 3,030 subjects were excluded from
the analysis due to any malignancy, immunosuppressive
therapy, known inﬂammatory diseases (arthritis, inﬂam-
matory bowel disease, psoriasis, etc.), pregnancy, steroidal
or nonsteroidal treatment (except for aspirin at a dose
of ≤325mg/day), acute infection, or invasive procedures
(surgery, catheterization, etc.) during the prior 6 months.
We further excluded 535 individuals with a history of
a proven atherothrombotic event (myocardial infarction,
cerebrovasculareventorperipheralarterialocclusivedisease)
and 556 due to diabetes mellitus. Finally, an additional 239
subjects were excluded due to missing data relating to any
of their anthropometric measurements or the inﬂammatory
variables. Following these exclusions the study group com-
prised 13,033 individuals (8,292 men and 4,741 women).2 International Journal of Inﬂammation
Table 1: Mean, SD and the quartiles of the diﬀerent anthropometric and laboratory variables in men (upper part) and women (lower part).
(a)
Men (N = 8,292) Mean SD 25th percentile Median 75th percentile
Age (years) 43 11 35 43 51
Waist (cm) 94 10 88 93 100
Weight (kg) 82 13 74 81 89
Waist/hip ratio 0.97 0.10 0.91 0.97 1.03
Waist/height ratio 0.54 0.06 0.49 0.53 0.57
BAI 24 4 21 23 26
BMI (kg/m2) 27 4 24 26 29
Systolic BP (mmHg) 124 14 115 120 130
Diastolic BP (mmHg) 78 8 71 78 82
Glucose (mg/dL) 92 9 86 91 97
HDL cholesterol (mg/dL) 50 10 43 49 56
LDL cholesterol (mg/dL) 122 31 100 120 142
Triglycerides (mg/dL) 109 2 76 108 153
Alcohol consumption
(glass/week) 1.2 2.3 0 0 2
Sport intensity
(hours/week) 2.3 2.7 0 2 3.3
Schooling years (years) 15 3 14 16 17
(b)
Women (N = 4,741) Mean SD 25th percentile Median 75th percentile
Age (years) 44 11 36 45 52
Waist (cm) 81 11 73 80 88
Weight (kg) 66 12 58 64 73
Waist/hip ratio 0.84 0.10 0.77 0.84 0.90
Waist/height ratio 0.50 0.07 0.45 0.49 0.54
BAI 29 5 25 28 31
BMI (kg/m2) 25 5 22 24 27
Systolic BP (mmHg) 116 15 105 114 125
Diastolic BP (mmHg) 74 8 70 72 80
Glucose (mg/dL) 88 9 82 88 94
HDL cholesterol (mg/dL) 65 15 54 63 73
LDL cholesterol (mg/dL) 117 32 94 114 136
Triglycerides (mg/dL) 89 2 63 86 121
Alcohol consumption
(glass/week) 0.5 1.4 0 0 0
Sport intensity
(hours/week) 1.8 2.5 0 1 3
Schooling years (years) 15 3 12 15 17
BAI: body adiposity index; BMI: Body mass index; HDL: high density lipoprotein;
LDL—low density lipoprotein.
2.2. Deﬁnition of Risk Factors. Results of the routine health
checkup were assessed employing certain deﬁnitions in
order to identify atherothrombotic risk factors in individ-
uals. These included diabetes mellitus which was deﬁned
as a fasting blood glucose concentration of ≥7.0mmol/L
(126mg/dL) or the intake of insulin or oral hypoglycemic
medications. Hypertension was deﬁned as a blood pressure
of ≥140/90mmHg on two separate measurements or the use
of antihypertensive medications. Dyslipidemia was deﬁned
according to the low density lipoprotein (LDL) or nonhigh
density lipoprotein (non-HDL) cholesterol concentrations
for those individuals displaying elevated triglyceride con-
centrations of >2.26mmol/L (200mg/dL) above the rec-
ommended levels (according to the risk proﬁle deﬁned byInternational Journal of Inﬂammation 3
Table 2: Frequency of cardiovascular risk factors and use of prescription medication in men and women.
Men (N = 8,292) Women (N = 4,741)
N%N%
Current smoker 1363 16.4 856 18.1
Past smoker 2015 24.3 913 19.3
Hypertension 1853 22.3 642 13.5
Dyslipidemia 2269 27.4 884 18.6
Family history of CHD 1162 14.0 801 16.9
Aspirin 368 4.4 92 1.9
Beta blockers 252 3.0 153 3.2
Calcium channel blockers 151 1.8 55 1.2
ACE inhibitors 233 2.8 76 1.6
ARBs 53 0.6 18 0.4
Statins 617 7.4 284 6.1
Fibrates 80 1.0 23 0.5
Oral contraceptives 684 14.4
Hormonal replacement therapy 381 8.0
CHD: Coronary heart disease; ACE: Angiotensin converting enzyme; ARB: Angiotensin II receptor blocker.
the updated ATP III recommendations [8]) or as using lipid
lowering medications. Smokers were deﬁned as individuals
who smoked at least 5 cigarettes per day while past smokers
had to have stopped smoking for at least 30 days prior to
examination.
2.3. Anthropometric Measurements. In this study, we used
common anthropometric measurements including: waist
(cm),weight(kg),BMI(kg/m2),BAI(bodyadiposity index),
waisttohipratio,andwaisttoheightratio.Ofthesevariables,
BAI is a new index that is less known. It is deﬁned as ((hip
circumference)/((height)1.5) − 18) that is better associated
with percent of body fat [9].
2.4. Laboratory Methods. The white blood cell count
(WBCC) and diﬀerential were performed by using the
Coulter STKS (Beckman Coulter, Nyon, Switzerland) elec-
tronic cell analyzer, quantitative ﬁbrinogen by the method
of Clauss [10], and a Sysmex 6000 (Sysmex-Corporation,
Hyaga, Japan) autoanalyzer while the high sensitivity C-
reactive protein (hs-CRP) was performed by using a Behring
BN II Nephelometer (DADE Behring, Marburg, Germany).
2.5. Statistical Analysis. All data was summarized and dis-
playedasmean(standard deviation (SD))forthe continuous
variables and as number of patients (expressed as a percent-
age) in each group for the categorical variables. Since the
hs-CRP and triglyceride concentrations displayed irregular
distributions, we used logarithmic transformation which
converted the distributions to normal ones for all statistical
procedures. Therefore all results of hs-CRP and triglyceride
concentrations are expressed as back transformed geometri-
cal means. The one-way Kolmogorov-Smirnov test was used
to assess the distributions.
Pearson’s partial correlations for confounding variables
were performed to evaluate the association between the dif-
ferent anthropometric measurements and the diﬀerent in-
ﬂammatory variables. All correlations were adjusted for age.
In order to evaluate and compare the diﬀerent anthro-
pometric measurements and their contribution to the vari-
ability of the diﬀerent inﬂammatory variables we performed
linear regression models, with the inﬂammatory variables
as the dependent variables and many potential and known
parameters as the independent variables. The parameters
entered into the model in addition to the diﬀerent anthropo-
metricmeasurementswereage,completelipidproﬁleinclud-
ing LDL, HDL, and triglycerides, diastolic and systolic blood
pressure measurements, glucose concentration, alcohol con-
sumption, sport intensity, number of schooling years (as
a measure of socioeconomic status), medications including
aspirin, beta blockers, calcium channel blockers, angiotensin
converting enzyme (ACE) inhibitors, angiotensin II receptor
blockers (ARBs), statins, ﬁbrates, and cardiovascular risk
factors including current and past smoking status and family
history of coronary heart disease (CHD). For women, the
models included the addition of two other variables—oral
contraceptive or hormonal replacement therapy usage. The
level of signiﬁcance used for all of the above analyses was
two tailed, P<0.05. The SPSS statistical package was used
to perform all statistical evaluation (SSPS Inc., Chicago, IL,
USA).
3. Results
We have presently analyzed a total of 13,033 individuals
(8,292 male and 4,741 female) at a mean (SD) age of
43 (11) years. The characteristic age, blood pressure, lipid
proﬁle, alcohol consumption, sport intensity, as well as the
ﬁve anthropometric measurements, are presented in Table 1,
while the respective percentage of individuals with diﬀerent4 International Journal of Inﬂammation
Table 3: Mean, SD and the quartiles of the diﬀerent inﬂammatory variables, in men (upper part) and women (lower part).
Men (N = 8,292) Mean SD 25th percentile Median 75th percentile
hsCRP (mg/L) 1.4 2.8 0.7 1.3 2.8
Fibrinogen (mg/dL) 281 57 242 276 315
WBC (∗103 cell/µL) 6.8 1.6 5.6 6.6 7.6
Women (N = 4,741) Mean S.D. 25th percentile Median 75th percentile
hsCRP (mg/L) 1.6 3.2 0.7 1.5 3.8
Fibrinogen (mg/dL) 310 59 270 307 345
WBC (∗103 cell/µL) 6.8 1.7 5.6 6.6 7.7
hsCRP: high-sensitivity C-reactive protein; WBC: white blood cell count.
Table 4: Age-adjusted Pearson partial correlation between the diﬀerent anthropometric measurements and the diﬀerent inﬂammatory
variables∗.
Men Waist Weight BMI BAI Waist/Hip Waist/Height
hsCRP 0.350 0.296 0.356 0.214 0.214 0.370
Fibrinogen 0.191 0.143 0.175 0.153 0.085 0.204
WBC 0.187 0.162 0.196 0.095 0.140 0.200
Women Waist Weight BMI BAI Waist/Hip Waist/Height
hsCRP 0.405 0.411 0.466 0.337 0.221 0.421
Fibrinogen 0.247 0.236 0.270 0.251 0.096 0.259
WBC 0.166 0.163 0.182 0.105 0.120 0.170
∗All above correlations are highly signiﬁcant (all P<0.001).
Table 5: Partial correlation between the diﬀerent anthropometric measurements and the diﬀerent inﬂammatory variables in the linear
regression models∗ after adjustment for many possible risk factors and medications‡.
Men Waist Weight BMI BAI Waist/Hip Waist/Height
hsCRP 0.279 0.233 0.286 0.178 0.144 0.297
Fibrinogen 0.152 0.108 0.137 0.132 0.048 0.165
WBC 0.104 0.090 0.116 0.067 0.063 0.115
Women Waist Weight BMI BAI Waist/Hip Waist/Height
hsCRP 0.332 0.353 0.401 0.284 0.138 0.344
Fibrinogen 0.214 0.204 0.233 0.216 0.058 0.222
WBC 0.081 0.094 0.104 0.056 0.045 0.082
∗Includedinthemodelsinadditiontotheanthropometricmeasurementswereage,systolicanddiastolicbloodpressuremeasurements,glucoseconcentration,
lipid proﬁle including HDL, LDL, and triglyceride concentration, sport intensity and alcohol consumption, number of schooling years (as a measure of
socioeconomic status), cardiovascular risk factors including smoking status, family history of CHD and medications including aspirin, beta blockers, calcium
channel blockers, ACE inhibitors, ARBs, statins, ﬁbrates, and for women also oral contraceptives or hormonal replacement therapy.
‡All above correlations are highly signiﬁcant (all P<0.001).
cardiovascular risk factors and relevant medications are
presented in Table 2. Since women have higher inﬂamma-
tory variables and diﬀerent anthropometric dimensions, we
present the data according to gender. As expected, men had
a higher weight and waist dimension (P<0.001). Table 3
presents the diﬀerent inﬂammatory variables in the cohort.
Women had higher hsCRP and ﬁbrinogen values (P<
0.001). A signiﬁcant age-adjusted Pearson partial correlation
was noted between all anthropometric measurements and
the concentration of hs-CRP, ﬁbrinogen and total white
blood cell count in both genders and is presented in Table 4.
There were higher correlation coeﬃcients in the female
gender group.
In order to evaluate and compare the diﬀerent anthro-
pometric variables as potential contributors to the variability
of the diﬀerent inﬂammatory variables we performed linear
regression models with various inﬂammatory variables and
cardiovascularriskfactors,medications,andanthropometric
measurements as potential confounders, and the results of
the partial correlation of the anthropometric variables are
presentedinTable 5.Ascanbeseen,evenaftercontrollingfor
many confounders, there was a strong correlation between
anthropometric measures and inﬂammatory biomarkers.
The commonly used BMI and waist circumference, but also
thelessknownwaisttoheightratio,weretheanthropometric
variables which demonstrated the strongest association withInternational Journal of Inﬂammation 5
the inﬂammatory biomarkers. The correlation was stronger
in women.
4. Discussion
There are multiple lines of evidence to suggest an association
between low grade inﬂammation, dysmetabolism, and vas-
cular disease. In this regard, it has been convincingly shown
that anthropometric measures are important for clinical and
epidemiological assessments. It might be relevant to deter-
mine what the relations are, if any, between them and the
presence of low grade inﬂammation. Such a relation might
support the link between abnormal measures and the pres-
ence of abnormal metabolism.
The main ﬁnding of our study is that among the com-
monly used inﬂammatory biomarkers that are available in
daily practice (hs-CRP, quantitative ﬁbrinogen, and WBC)
the hs-CRP correlates best with the diﬀerent anthropometric
measures. An additional relevant ﬁnding is the similar
magnitude of correlation between diﬀerent anthropometric
variables and the diﬀerent inﬂammatory variables with
strong association for BMI and waist circumference. The
correlation was stronger in females. This point is of special
relevance due to the introduction of modern scales, into
most of the modern clinics. They automatically calculate the
individual’s BMI due to their ability to measure height using
optic measures.
We have shown that anthropometric measurements, par-
ticularly waist circumference and BMI, are strongly associ-
atedwith inﬂammation. The high correlations between these
variables and the diﬀerent inﬂammatory variables were sig-
niﬁcant also after controlling for many known and possible
confounding parameters. This link has clinical implementa-
tions since anthropometric measurements are used in order
to evaluate the metabolic status of patients. It is well known
that the visceral fat of the abdomen is proinﬂammatory. In
fact, the fat can be inﬁltrated by macrophages that can lead
to insulin resistance and endothelial dysfunction [2, 4, 11].
According to our results, there is no need to measure the
more cumbersome hip, waist/hip, or waist/height ratios as
they are no superior to simpler measurements.
Our data is also supported by studies that show that the
metabolic syndrome is closely related to the inﬂammatory
status of the patient [12]. Since the abdominal fat is known
to be proinﬂammatory and a main cause of the metabolic
syndrome, it is also the main cause of waist circumference
and BMI.
Inconclusion,mostofthecommonusedanthropometric
variables are similarly correlated with inﬂammatory vari-
ables. The clinician should choose the variable that he/she
ﬁnds easiest to use.
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